QTLs in Region (mRatBN7.2)
4145119 | Mcs25 | Mammary carcinoma susceptibility QTL 25 | | 0.0001 | mammary gland integrity trait (VT:0010552) | ratio of deaths to total study population during a period of time (CMO:0001023) | 6 | 10894415 | 110548006 | Rat |
9590290 | Uminl2 | Urine mineral level QTL 2 | 3.96 | 0.001 | urine mineral amount (VT:0015086) | urine electrolyte level (CMO:0000593) | 6 | 38783989 | 83783989 | Rat |
70176 | Mcsm1 | Mammary carcinoma susceptibility modifier QTL 1 | | | mammary gland integrity trait (VT:0010552) | mammary tumor number (CMO:0000343) | 6 | 58632962 | 103632962 | Rat |
1558641 | Cm47 | Cardiac mass QTL 47 | 2.9 | 0.001 | heart mass (VT:0007028) | heart wet weight (CMO:0000069) | 6 | 57730540 | 104085867 | Rat |
634307 | Bp141 | Blood pressure QTL 141 | 4 | | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 6 | 35230417 | 80230417 | Rat |
2293839 | Kiddil2 | Kidney dilation QTL 2 | 4.8 | | kidney pelvis morphology trait (VT:0004194) | hydronephrosis severity score (CMO:0001208) | 6 | 20866422 | 81133036 | Rat |
1576309 | Emca7 | Estrogen-induced mammary cancer QTL 7 | 4 | | mammary gland integrity trait (VT:0010552) | mammary tumor number (CMO:0000343) | 6 | 15107216 | 107351382 | Rat |
9590140 | Scort4 | Serum corticosterone level QTL 4 | 14.49 | 0.001 | blood corticosterone amount (VT:0005345) | plasma corticosterone level (CMO:0001173) | 6 | 38783989 | 83783989 | Rat |
9590306 | Scort18 | Serum corticosterone level QTL 18 | 2.88 | 0.001 | blood corticosterone amount (VT:0005345) | plasma corticosterone level (CMO:0001173) | 6 | 38783989 | 83783989 | Rat |
1578665 | Bss16 | Bone structure and strength QTL 16 | 4.4 | | femur morphology trait (VT:0000559) | bone trabecular cross-sectional area (CMO:0002311) | 6 | 11735669 | 72593685 | Rat |
2293841 | Kiddil4 | Kidney dilation QTL 4 | 4.4 | | kidney pelvis morphology trait (VT:0004194) | hydronephrosis severity score (CMO:0001208) | 6 | 20866422 | 81133036 | Rat |
4889848 | Pur25 | Proteinuria QTL 25 | 14 | 0.003 | urine total protein amount (VT:0000032) | urine total protein excretion rate (CMO:0000756) | 6 | 56728562 | 90198260 | Rat |
1641898 | Colcr4 | Colorectal carcinoma resistance QTL4 | 3.71 | 0.0007 | intestine integrity trait (VT:0010554) | well differentiated malignant colorectal tumor surface area measurement (CMO:0002077) | 6 | 20338777 | 62613667 | Rat |
634330 | Pia16 | Pristane induced arthritis QTL 16 | 3.9 | | joint integrity trait (VT:0010548) | arthritic paw count (CMO:0001460) | 6 | 45790088 | 104200226 | Rat |
1578668 | Bmd14 | Bone mineral density QTL 14 | 3.8 | | femur mineral mass (VT:0010011) | total volumetric bone mineral density (CMO:0001728) | 6 | 11735669 | 72593685 | Rat |
6893340 | Cm77 | Cardiac mass QTL 77 | 0.26 | 0.57 | heart mass (VT:0007028) | heart weight to body weight ratio (CMO:0000074) | 6 | 33309549 | 81132889 | Rat |
2301972 | Bp325 | Blood pressure QTL 325 | 4.8 | | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 6 | 1 | 72227641 | Rat |
1331779 | Rf38 | Renal function QTL 38 | 2.876 | | kidney blood vessel physiology trait (VT:0100012) | absolute change in renal vascular resistance (CMO:0001900) | 6 | 32074428 | 72227641 | Rat |
1354664 | Slep2 | Serum leptin concentration QTL 2 | 4.49 | | blood leptin amount (VT:0005667) | serum leptin level (CMO:0000780) | 6 | 16536140 | 71636405 | Rat |
1300143 | Rf14 | Renal function QTL 14 | 2.92 | | renal blood flow trait (VT:2000006) | absolute change in renal blood flow rate (CMO:0001168) | 6 | 34434137 | 77102317 | Rat |
1354632 | Scl29 | Serum cholesterol level QTL 29 | 3.74 | | blood cholesterol amount (VT:0000180) | serum total cholesterol level (CMO:0000363) | 6 | 35098709 | 71636405 | Rat |
6893332 | Cm74 | Cardiac mass QTL 74 | 0.4 | 0.64 | heart mass (VT:0007028) | heart weight to body weight ratio (CMO:0000074) | 6 | 57730540 | 104085867 | Rat |